Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Raheleh Niavarani

Post-doctoral fellow


Tumor microenvironment consists of a dynamic ecosystem of different cells, including immune cells, and immunotherapy is one of the main pillars of treating cancer along with chemotherapy and radiotherapy; therefore, understanding how immune cells’ function affects tumor cell growth or eradication is essential to predict the patient's outcome after treatment. My research interest is to study the mechanism by which epigenetic enzymes control immune cells’ function, especially in the context of cancer. 


I received my bachelor’s degree in Biology Health Science from the University of Bishops (Canada) and PhD in Immunology from the University of Sherbrooke (Canada).